The pathogenesis of morbidity associated with hyponatremia is postulated to be determined by the state of intracellular cerebral osmolytes. Previously inaccessible, these metabolites can now be quantitated by proton magnetic resonance spectroscopy. An in vivo quantitative assay of osmolytes was performed in 12 chronic hyponatremic patients (mean serum sodium 120 meq/liter) and 10 normal controls. Short echo time proton magnetic resonance spectroscopy of occipital gray and parietal white matter locations revealed dramatic reduction in the concentrations of several metabolites. In gray matter, myo-inositol was most profoundly reduced at 49% of control value. Choline containing compounds were reduced 36%, creatine/phosphocreatine 19%, and N-acetylaspartate 11% from controls.
Introduction
Physicians treating severe hyponatremia have been faced with a dilemma: significant neuropathological disorders and death have been attributed to both hyponatremia and its correction. An abrupt fall in serum sodium concentration ( [Na+]) is associated with seizures, respiratory arrest, coma, and death (1). Conversely, aggressive treatment of hyponatremia increases the risk for demyelinating lesions of white matter (2) (3) (4) . Hence, the risks of prolonging the hyponatremic state must be balanced against the iatrogenic consequences of prompt correction. Therapeutic recommendations to date have focused on rate and magnitude of correction to match the perceived duration of hyponatremia but frequently lead to a compromise between aggressive and conservative strategies, particularly for a symptomatic patient without an acute history (5) (6) (7) (8) (9) .
Experimental evidence has linked the development of demyelinating lesions to rapid correction of serum [Na ] levels after the depletion of intracellular organic osmolytes. Perhaps as an evolutionary adaptation to protect against swelling, the brain differs from other tissues in response to osmotic stress ( 10, 11) . Acute hyponatremia is associated with a transient phase of brain swelling followed by brain electrolyte loss to control volume (10, 12) . Brain water, however, may not approach normal until intracellular organic osmolytes slowly decline over days (13). Systems of organic molecules (e.g., amino acids, polyols, and methylated amines) have evolved to counteract the perturbing effects of solutes on protein structure (14) . Rodent models of adapted hyponatremia corrected aggressively with hypertonic saline have demonstrated a lag in the recovery of organic osmolytes and a transient overshoot of brain sodium and chloride (15) (16) (17) . The elevated ratio of tissue ions relative to organic osmolytes may be the pathogenic mechanism of brain injury (15) . Hence, the solution to the clinical dilemma would be to monitor in vivo intracellular osmolytes and correct the [Na'] at a rate proportional with their reaccumulation.
Under hyper-and hypotonic conditions, alterations in rat brain concentrations of myo-inositol (mI),'i glycerophosphocholine (GPC), creatine/phosphocreatine (Cr), and glutamate/ glutamine (Glx) have identified these compounds as osmolytes ( 15, 16, (18) (19) (20) . Image-guided short echo time proton magnetic resonance spectroscopy (MRS) can resolve these compounds in human brain in vivo (21, 22 (21 ) . Scaling of peak height was accomplished by two methods. The height of the Cr peak was assigned to 1.00 to provide a relative scale. For absolute scaling, the spectra were multiplied by a correction factor that accounted for percent cerebrospinal fluid in the voxel, coil loading, and voxel size. Summed spectra were obtained by vector summation and scalar division to display an average spectrum. Difference spectra were produced by vector subtraction and magnified with scalar multiplication.
Metabolite amounts were calculated both as a ratio relative to Cr peak intensity and as absolute concentrations expressed in mmol/kg wet weight. Metabolite ratios relative to Cr were determined in an operator-independent manner from peak amplitudes after LorentzGauss transformation (27) . The quantitative schema uses peak integrals and includes a correction for brain compartmentation whereby the voxel was divided into brain water (intra-and extracellular), cerebrospinal fluid, and "dry matter" based on water T2 characteristics (29) . Adjustments for T1 and T2 relaxation were also used, and the combined method is known to yield reproducible results in close agreement with other in vitro methods (30) . Results are expressed as means±SD, and statistical significance was determined using Student's t test.
Results
Characteristics of the patients are listed in Table I sence of systemic illness or medications known to cause hyponatremia. Congestive heart failure (CHF) was believed to be etiologic in 5 of 12 patients. In three patients, hyponatremia improved after discontinuation of medications associated with inappropriate antidiuresis. Symptoms of hyponatremia included malaise (n = 8), weakness (n = 7), and confusion (n = 3) lasting for several days or weeks before presentation. Two patients were asymptomatic. All patients were treated with water restriction, two received demeclocycline, one received hypertonic saline, but none had significantly corrected serum [Na+] by the time of MRS. No patient developed adverse neurologic symptoms or the osmotic demyelination syndrome. Fig. 1 shows representative proton magnetic resonance spectra from gray and white matter in a control and patient 11. These spectra are scaled relative to Cr peak height. Four major peaks are readily apparent and have been assigned to N-acetylaspartate (NAA), Cr, Cho, and mI. Smaller peaks present in the figures include the alpha and beta/gamma resonances of Glx (a-Glx and .,y-Glx) and scyllo-inositol (sI). A decrease in ml, sI, and Cho can be appreciated in patient spectra compared with the control in both gray and white matter. Table II shows that significant and sizable abnormalities in the metabolite amplitude ratios of both gray and white matter are present in patients with moderate hyponatremia. In gray matter, significant reductions in ml:Cr (30%) Cho:Cr (15%) ratios were noted. NAA:Cr and Glx:Cr were not altered significantly. Similar changes of metabolite ratios in white matter were found (n = 3). Glx was not significantly reduced in white matter. An increase in the white matter a-Glx:Cr ratio unaccompanied by a change in /,y-Glx:Cr ratio may reflect statistical scatter.
To determine whether these changes in metabolite ratios were due to changes in the concentrations of the relevant metabolites in the brain, 11 of 12 patients underwent a quantitative examination. Gray and white matter data listed in Table III change in concentration of these four metabolites is a reduction of 29%, from 28±4 mmol/kg in the controls to 20±3 mmol/kg in the hyponatremic patients. More than half (58%) of this change is due to depletion of mI. Fig. 2 depicts these quantitative changes directly. Here, the summed spectra of patients (A) and controls (B) are displayed with the difference spectrum (C). Note that NAA, Cr, Cho, and mI all appear as negative peaks as indicated by the quantitative data above. Additionally, a reduction in both the a and ,l, 'y region of Glx is suggested in the difference spectrum, even though this does not appear as a difference in the metabolite ratios (see Table H up, and difference spectra depicted in Fig. 3 . Other patients with incomplete correction of hyponatremia showed measurable recovery of cerebral osmolytes but retained spectroscopic abnormalities. Fig. 4 (Table IV) . The mean interval between the initial (hyponatremia) and follow-up ("recovery") MRS examinations was 10.8 wk, consistent with the expectedly very slow rate of restoration of intracerebral osmotic status.
Spectra obtained from a subset of patients (n = 3) at different TR revealed no significant changes in T1 of NAA, Cr, Cho, and mI from that reported by Kreis et al. (30) . Determination of T2 of NAA, Cr, Cho, and mI in two patients also did not reveal significant changes, indicating that the changing spectral peak areas determined during hyponatremia reflect changing concentrations. However, due to the severe reduction in [Cho] and [ml] , the determination of their T2 is less precise.
Discussion
As far as we are aware, the present results represent the first direct demonstration of quantitative cerebral osmolyte abnor- Values are means±SD expressed in mmol/kg wet wt. P determined using Student's t test.
malities associated with hyponatremia in humans. Our results are consistent with several earlier animal studies in all of which osmolyte assays were performed in vitro ( 15-18, 20, 31) . The changes determined by proton MRS are quite sizable and can be readily observed in the individual patient and followed over time.
The details of cerebral osmolyte composition appear similar to those described in the rat brain (15) (16) (17) . The significant absolute reductions in ml (49%), Cho (36%), and Cr (19%) in this study are comparable with changes of ml, GPC, and Cr in hyponatremic rats (15, 16, 18) . GPC cannot be separately assayed in in vivo proton MRS but comprises up to half of the Cho peak (32, 33). Glx is an important osmolyte in rat brain.
We are unable to demonstrate a significant reduction in Glx:Cr in humans, possibly because of the fall in [Cr] . However, [Glx] does appear to be reduced in the difference spectrum (Fig. 2) . Although not an osmolyte per se and infrequently measured in studies of osmolar stress, our demonstration of a reduction in [NAA] (-11%) is supported in a rat model of acute hyponatremia (31). Alternatively, the NAA peak may be factitiously low secondary to a change of another metabolite underlying the NAA and P, y-Glx region of the spectrum. Of the four metabolites quantitated in this study by MRS, mI accounts for 58% of the total change and is therefore the predominant cerebral osmolyte in the human brain. A minimum estimate of the total cerebral osmolyte change detected by 'H MRS is -6.57 mosM/ kg in gray matter (see Table HI ) and -4.43 mosM/kg in white matter, representing 16% and 11%, respectively, of the mean reduction in serum osmolality of -42 mosM/kg (Table I) . However, the true effect is probably somewhat greater for the following reason. Because [Cr] is significantly reduced, we believe that Glx, the sum of glutamate and glutamine, is similarly reduced by -20%. Assuming Glx 16 mmol/kg, this represents a further reduction of measured cerebral osmolytes of -3 mosM/kg and brings the total cerebral osmolyte loss in hyponatremia to -23.3% in gray matter and -18.1% of the change in plasma osmolality.
Although an increase in brain water that returns toward normal with adaptation to hypoosmolality is expected, there was no observed alteration in the size of the compartments of cerebral water in patients versus controls. Rodent models of chronic hyponatremia have reported a 0.4-6% increase in brain water content ( 10, 13, (15) (16) (17) . In our patient sample, adaptation may become so complete as to be impossible to detect with present MRS techniques. Alternatively, because the three-compartment model used in our methods is unable to distinguish between intracellular (-80-90%) and extracellular (-10-20%) fluid, relative changes in these compartments cannot be excluded. Nevertheless, it is unlikely that the brain water content or ratio of intracellular to extracellular fluid compartments increased enough to completely account for the 20-50% reduction of osmolytes by dilution; therefore reduced synthesis, increased catabolism, or impaired influx is implied.
There was no correlation between the extent of the reduction in cerebral [ml] and serum [Na+] or osmolality (r < 0.3). In addition to severity, one would predict duration of hyponatremia to be a significant variable but somewhat difficult to control in a study of this design. Assuming that all of our patients reached a steady state where intracellular osmolytes equilibrated with serum tonicity, the lack of a correlation indicates the presence of other independent factors that contribute to the regulation of the intracellular osmolytes (e.g., malnutrition, glucose metabolism, and presence of other unmeasured osmolytes). It is of particular interest to note that normonatremic patients with hepatic encephalopathy have evidence of altered cerebral osmolyte metabolism by proton MRS (34) . Even patients with subclinical hepatic encephalopathy demonstrate reduced ml:Cr and Cho:Cr but, in contrast with hyponatremics, have elevated Glx:Cr (35) . Thus the higher observed risk of myelinolysis in alcoholics and cirrhotics may be explained by an independent effect of liver disease on cerebral myo-inositol metabolism (36, 37) .
Although the time course of recovery of cerebral osmolytes has not been established in the present studies, it is clearly prolonged, being measured in weeks, not days. As pointed out by Narins (38) 8 years ago, the controversy over therapy of symptomatic hyponatremia cannot be solved without a prospective study with stratification of defined groups and careful attention of brain metabolism. It now appears that a tool is available to undertake such a study and guide therapy. One could monitor osmolyte concentrations in symptomatic patients with hyponatremia and treat at a proportional rate. Those patients with unacceptably low osmolytes may require alternative modalities (urea, colchicine, steroids) (39-41) to protect against osmotic stress.
In summary, this study demonstrates the reversible reduction in human cerebral organic osmolyte concentrations in response to hypoosmolar stress predicted by animal studies. MRS of brain metabolism during osmolar stress will ultimately con- 4 . NS = P > 0.05. 1:
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